ArticleFrontiers in oncology2026
Clinical value of habitat radiomics within the 2-cm edema zone surrounding the postoperative residual cavity in predicting glioma recurrence.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the predictive value of radiomics from the 2-cm edema zone surrounding the postoperative residual cavity for progression-free survival (PFS), using habitat analysis based on multimodal magnetic resonance imaging (MRI) and integrating clinical data to construct a nomogram model. Methods: This retrospective study analyzed MRI and clinical data from 89 postoperative glioma patients. The 2-cm edema zone surrounding the postoperative residual cavity was defined as the region of interest (ROI), and habitat subregions were created using K-means clustering based on contrast-enhanced T1-weighted imaging (CE-T1WI) and apparent diffusion coefficient (ADC) sequences. Radiomic features were extracted from the ROI and each habitat subregion, followed by Least Absolute Shrinkage and Selection Operator (LASSO)-Cox selection to generate radiomic scores. Clinical, traditional radiomic, and high-risk habitat models were constructed, and the high-risk habitat nomogram was further developed and evaluated. Results: Four habitat subregions were identified. A total of 944 radiomic features were extracted from each subregion and the ROI; the most relevant features were used to generate radiomic scores. The high-risk habitat nomogram was constructed by combining clinical factors. The nomogram showed good calibration, with observed values closely matching predictions. In the validation cohort, the time-dependent AUCs for predicting 1-, 2-, and 3-year PFS were 0.813, 0.933, and 0.930, respectively. Compared with the clinical and traditional radiomic models, the high-risk habitat nomogram achieved a C-index of 0.916. Conclusion: The nomogram based on high-risk habitats in the 2-cm edema zone surrounding the postoperative residual cavity provides significant predictive value for PFS and aids in targeting postoperative radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.